CSX Corp. (CSX) Testing Investors’ Patience Right Now

Currently, there are 1.96B common shares owned by the public and among those 1.95B shares have been available to trade.

The company’s stock has a 5-day price change of -1.53% and 5.87% over the past three months. CSX shares are trading 6.09% year to date (YTD), with the 12-month market performance up to 24.30% higher. It has a 12-month low price of $29.03 and touched a high of $40.12 over the same period. CSX has an average intraday trading volume of 11.59 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.01%, -0.32%, and 10.43% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of CSX Corp. (NASDAQ: CSX) shares accounts for 75.44% of the company’s 1.96B shares outstanding.

It has a market capitalization of $72.06B and a beta (3y monthly) value of 1.18. The stock’s trailing 12-month PE ratio is 19.94, while the earnings-per-share (ttm) stands at $1.84. The company has a PEG of 2.03 and a Quick Ratio of 0.91 with the debt-to-equity ratio at 1.57. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.75% over the week and 1.55% over the month.

Analysts forecast that CSX Corp. (CSX) will achieve an EPS of $0.45 for the current quarter, $0.5 for the next quarter and $2.19 for 2025. The lowest estimate earnings-per-share for the quarter is $0.42 while analysts give the company a high EPS estimate of $0.47. Comparatively, EPS for the current quarter was $0.48 a year ago. Earnings per share for the fiscal year are expected to increase by 6.74%, and 11.30% over the next financial year. EPS should grow at an annualized rate of 9.83% over the next five years, compared to 7.59% over the past 5-year period.

Looking at the support for the CSX, a number of firms have released research notes about the stock. TD Cowen stated their Market Perform rating for the stock in a research note on January 25, 2024, with the firm’s price target at $32-$36. JP Morgan was of a view on October 11, 2023 that the stock is Overweight, while BofA Securities gave the stock Buy rating on September 08, 2023, issuing a price target of $34- $36. BofA Securities on their part issued Neutral rating on August 04, 2023.

Most Popular

Related Posts